Coe Capital Management Llc increased its stake in Vulcan Matls Co (VMC) by 30.5% based on its latest 2018Q3 regulatory filing with the SEC. Coe Capital Management Llc bought 4,395 shares as the company’s stock declined 5.28% with the market. The hedge fund held 18,803 shares of the mining & quarrying of nonmetallic minerals (no fuels) company at the end of 2018Q3, valued at $2.09M, up from 14,408 at the end of the previous reported quarter. Coe Capital Management Llc who had been investing in Vulcan Matls Co for a number of months, seems to be bullish on the $13.66B market cap company. The stock increased 1.58% or $1.61 during the last trading session, reaching $103.47. About 1.23M shares traded or 5.13% up from the average. Vulcan Materials Company (NYSE:VMC) has declined 18.69% since February 10, 2018 and is downtrending. It has underperformed by 18.69% the S&P500. Some Historical VMC News: 03/05/2018 – VULCAN MATERIALS 1Q ADJ EPS CONT OPS 44C, EST. 23C; 05/03/2018 Grandin Sand Plant Earns Wildlife Habitat Council Conservation Certification; 11/04/2018 – REG-INVITATION TO RAPALA VMC CORPORATION’S CAPITAL MARKETS DAY 2018; 15/05/2018 – Eminence Capital Adds Vulcan Materials, Exits Mondelez: 13F; 03/05/2018 – VULCAN MATERIALS CO – ALSO PLAN FOR $350 MLN IN INTERNAL GROWTH CAPITAL EXPENDITURES DURING 2018; 26/03/2018 – Vulcan Minerals Inc. — Options Voisey’s Bay South Claims to Fjordland Exploration Inc; 03/05/2018 – VULCAN MATERIALS CO – SHIPMENTS INCREASED 2.3 MLN TONS, OR 6 PERCENT, TO 40.5 MLN TONS IN QTR; 03/04/2018 – Stratasys Announces Formation of Vulcan Labs, Inc; 03/05/2018 – Vulcan Materials 1Q EBITDA $167.7M; 05/03/2018 – VULCAN MATERIALS CO – EXCHANGE OFFER WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON MARCH 19, 2018

Parnassus Investments decreased its stake in Bristol (BMY) by 2.78% based on its latest 2018Q3 regulatory filing with the SEC. Parnassus Investments sold 100,000 shares as the company’s stock declined 13.60% with the market. The institutional investor held 3.50 million shares of the major pharmaceuticals company at the end of 2018Q3, valued at $217.28M, down from 3.60M at the end of the previous reported quarter. Parnassus Investments who had been investing in Bristol for a number of months, seems to be less bullish one the $81.98B market cap company. The stock increased 0.34% or $0.17 during the last trading session, reaching $50.22. About 9.62M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 14.97% since February 10, 2018 and is downtrending. It has underperformed by 14.97% the S&P500. Some Historical BMY News: 27/03/2018 – U.S. FOOD AND DRUG ADMINISTRATION (FDA) ACCEPTS BRISTOL-MYERS SQUIBB’S APPLICATION FOR OPDIVO (NIVOLUMAB) PLUS YERVOY (IPILIMUMAB) FOR PREVIOUSLY TREATED PATIENTS WITH MSI-H OR DMMR METASTATIC COLORECTA; 18/05/2018 – FDA – MERCK, GENENTECH HAVE STOPPED ENROLLING PATIENTS WHOSE TUMORS HAVE PD-L1 LOW STATUS TO KEYTRUDA/TECENTRIQ MONOTHERAPY ARMS PER DMCS’ RECOMMENDATIONS; 10/04/2018 – Oncolytics Biotech(R) Presents Positive REOLYSIN(R) Data in Combination with Keytruda and anti-CD73 at International; 26/04/2018 – BRISTOL-MYERS SQUIBB CO – U.S. REVENUES INCREASED 1% TO $2.8 BILLION IN THE QUARTER COMPARED TO THE SAME PERIOD A YEAR AGO; 08/03/2018 – Rhode Island DoA: Bristol Fourth of July Committee Thu, 3/8/2018, 7:00 PM; 01/05/2018 – Merck Boosts Outlook as Keytruda Sales Surpass Diabetes Drugs; 05/04/2018 – Rhode Island DoA: Bristol Historic District Commission Thu, 4/5/2018, 8:00 PM; 17/05/2018 – Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab); 05/04/2018 – Rhode Island DoA: Bristol Town Council Thu, 4/5/2018, 7:30 PM; 04/04/2018 – MOVES-Hirtle Callaghan, HSBC Private Banking, RPMI Railpen, BMY Mellon AMNA

Parnassus Investments, which manages about $10.39 billion and $26.19 billion US Long portfolio, upped its stake in Waste Management Inc. (NYSE:WM) by 336,695 shares to 5.81 million shares, valued at $524.68M in 2018Q3, according to the filing. It also increased its holding in Signature Bank (NASDAQ:SBNY) by 21,068 shares in the quarter, for a total of 1.29 million shares, and has risen its stake in Johnson Controls International Plc.

Among 25 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 8 have Buy rating, 1 Sell and 16 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 100 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Tuesday, September 20 by Citigroup. The rating was initiated by Atlantic Securities on Friday, December 18 with “Underweight”. Barclays Capital maintained Bristol-Myers Squibb Company (NYSE:BMY) on Tuesday, December 1 with “Equal Weight” rating. The firm has “Underweight” rating by Piper Jaffray given on Monday, August 24. On Thursday, July 27 the stock rating was maintained by Piper Jaffray with “Hold”. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Neutral” rating by Credit Suisse on Friday, July 27. The firm has “Buy” rating given on Tuesday, April 17 by Guggenheim. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by Piper Jaffray on Thursday, October 26. The stock has “Neutral” rating by Hilliard Lyons on Monday, May 23. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Hold” rating given on Monday, October 16 by Jefferies.

Investors sentiment increased to 0.88 in Q3 2018. Its up 0.10, from 0.78 in 2018Q2. It increased, as 41 investors sold BMY shares while 532 reduced holdings. 119 funds opened positions while 388 raised stakes. 1.14 billion shares or 0.62% less from 1.14 billion shares in 2018Q2 were reported. Los Angeles Mgmt Equity accumulated 0.66% or 2.04 million shares. Congress Asset Ma reported 0% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). 941,865 are held by Aviva Pcl. Ajo Lp, a Pennsylvania-based fund reported 2.55 million shares. Credit Agricole S A has 0.28% invested in Bristol-Myers Squibb Company (NYSE:BMY). Neumann Cap Mgmt Limited Liability Corp stated it has 10,839 shares or 0.4% of all its holdings. Gotham Asset Mngmt Ltd Liability Corp accumulated 195,005 shares or 0.17% of the stock. Canada Pension Plan Inv Board holds 5.47 million shares. Mitsubishi Ufj Secs Communication Ltd reported 0.09% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Sectoral Asset Management holds 240,697 shares. Intact holds 0.19% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 85,100 shares. Smith Chas P And Assoc Pa Cpas holds 0.04% or 5,836 shares. Green Square Capital Lc accumulated 3,889 shares. Diligent Invsts Ltd Company accumulated 14,119 shares. Elm Advisors Ltd Liability Com holds 6,763 shares.

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Seekingalpha.com which released: “You Should Not Miss Bristol-Myers Squibb In 2018 – Seeking Alpha” on August 11, 2018, also Seekingalpha.com with their article: “BMS Is A Buy On The Dip – Seeking Alpha” published on October 30, 2018, Seekingalpha.com published: “Cancer Research Highlight: Yet Again, It’s Bristol Drawing The Short Stick In Lung Cancer – Seeking Alpha” on October 15, 2018. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Fool.com and their article: “Is Bristol-Myers Squibb Company a Buy? – The Motley Fool” published on September 09, 2018 as well as Fool.com‘s news article titled: “3 Top Dividend Stocks Selling at a Discount Right Now – Motley Fool” with publication date: January 13, 2019.

Among 16 analysts covering Vulcan Materials Company (NYSE:VMC), 13 have Buy rating, 1 Sell and 2 Hold. Therefore 81% are positive. Vulcan Materials Company had 55 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Buy” rating by Argus Research on Friday, August 14. Jefferies initiated it with “Hold” rating and $122.0 target in Wednesday, October 11 report. The firm has “Buy” rating by Citigroup given on Friday, January 4. The stock of Vulcan Materials Company (NYSE:VMC) earned “Neutral” rating by Bank of America on Wednesday, November 16. The stock has “Buy” rating by RBC Capital Markets on Monday, October 9. RBC Capital Markets maintained it with “Buy” rating and $150.0 target in Friday, November 3 report. The firm has “Neutral” rating by DA Davidson given on Thursday, October 11. The rating was maintained by Jefferies with “Hold” on Monday, April 23. The firm earned “Hold” rating on Wednesday, January 17 by Jefferies. The stock has “Buy” rating by Citigroup on Thursday, January 25.

More notable recent Vulcan Materials Company (NYSE:VMC) news were published by: Investorplace.com which released: “7 Recession-Proof Stocks to Buy … According to Goldman Sachs – Investorplace.com” on January 25, 2019, also Seekingalpha.com with their article: “Vulcan Materials declares $0.31 dividend – Seeking Alpha” published on February 08, 2019, Seekingalpha.com published: “Best And Worst Performing S&P 500 Stocks On Earnings – Seeking Alpha” on November 03, 2018. More interesting news about Vulcan Materials Company (NYSE:VMC) were released by: and their article: “Midterms And Stock Market: Potential Winners, Losers From The Coming Election – Benzinga” published on October 13, 2018 as well as Seekingalpha.com‘s news article titled: “Vulcan Materials Company 2018 Q3 – Results – Earnings Call Slides – Seeking Alpha” with publication date: October 30, 2018.

Coe Capital Management Llc, which manages about $649.91M and $101.28M US Long portfolio, decreased its stake in Fastenal Co (NASDAQ:FAST) by 6,030 shares to 25,365 shares, valued at $1.47 million in 2018Q3, according to the filing.